Rayonier Advanced Materials (RYAM) Q2 2026 earnings review
Price-Over-Volume Strategy Taking Hold, but Paperboard Drag Persists
Rayonier Advanced Materials (RYAM) showed stabilizing financials in Q2 2026 under new CEO Daniel Krawczyk. The company's aggressive 'price-over-volume' strategy in its core Cellulose Specialties (CS) segment is working: a 21% YoY price hike successfully offset a 23% volume drop. Total Revenue accelerated to $376M (+11% YoY), and Adjusted EBITDA rebounded sharply to $40M from Q1's dismal $8M. However, the turnaround is uneven. The newly formed Paperboard & High Yield Pulp segment is bleeding cash, posting a $27M operating loss amidst a 10% pricing drop. The overarching narrative hinges on the Q4 conclusion of the company's formal strategic review.
🐂 Bull Case
The company successfully forced a 21% YoY price increase in its high-margin Cellulose Specialties business. Customers accepted the hikes, validating the tight supply/demand narrative.
Management successfully flexed idle CS capacity into Cellulose Commodities, driving a 94% YoY volume increase in commodities to absorb fixed costs while preserving specialty pricing.
🐻 Bear Case
PB & HYP posted an abysmal $27M operating loss (including a $13M impairment). Even stripping out the impairment, losses expanded due to a 10% price decline from U.S. oversupply.
The company remains under a formal strategic review. Operations are improving, but a heavily leveraged balance sheet (4.2x net secured leverage) makes execution critical before a 2026 debt wall.
⚖️ Verdict: ⚪
Neutral. The core Cellulose Specialties business is executing its turnaround masterfully, but the Paperboard/High Yield Pulp division remains a toxic asset dragging down total earnings. Investors are essentially waiting for the Q4 strategic review conclusion.
Key Themes
Cellulose Specialties: Successful Price Reset
Accelerating. The central pillar of RYAM's turnaround—forcing price hikes to recapture inflation-lost margins—is materializing. In Q2, CS average sales price surged 21% YoY to $2,193 per ton. While this drove a 23% intentional reduction in volume (to 86k tons), the math works: operating income for the High Purity Cellulose segment grew 45% YoY to $29M, heavily driven by this price realization.
Dynamic Capacity Shift to Commodities
Stable. To offset the 23% volume loss in CS, management aggressively shifted idle capacity to Cellulose Commodities (CC). CC volumes exploded 94% YoY to 124,000 tons. While CC prices dropped 11% YoY to $815/ton due to softer global markets, this volume pivot was crucial to absorbing plant fixed costs and maintaining overall High Purity Cellulose profitability.
Lower Wood Costs & Cost Control
Stable. A major driver of the $9M YoY increase in High Purity Cellulose operating income was lower wood costs and reduced discretionary spending. These structural cost improvements are providing necessary padding while the company navigates the lower-margin CC product mix.
Paperboard & High Yield Pulp Collapse
Accelerating negative trend. This segment is a severe drag. Despite sales volumes jumping 22% (driven by folding packaging and delayed Q1 Indonesia orders), operating loss ballooned 286% YoY to $27M. The contradiction is stark: higher volumes, much worse margins. The root causes are macro-driven: a 10% average price drop due to a new U.S. capacity startup mid-2025, Asian oversupply, and global economic uncertainty.
Inflationary Pressures in Chemicals and Logistics
Stable. While wood costs were a tailwind, management explicitly flagged that higher inflation in chemicals and logistics costs partially offset the gains in the High Purity Cellulose segment. Given the heavy volumes of low-margin CC shipped this quarter, any further logistics inflation could severely compress total gross margins.
Strategic Review Clock is Ticking
The new CEO, Daniel Krawczyk, reiterated that the comprehensive review of strategic alternatives is the 'top priority.' The board expects to communicate a 'clear path forward' during Q4 2026. This limits management's runway to fix the PB&HYP segment before a potential sale, merger, or capital structure action is initiated.
Capital-Light Biomaterials Strategy
Management confirmed they are retaining a 'capital-light interest' in the Altamaha Green Energy (AGE) project through land and prior investments. This preserves upside without requiring additional cash equity—a critical pivot given the company's tight liquidity constraints and prior struggles to find the $46M equity portion originally required.
Other KPIs
Stable sequentially, hovering at 4.2 times covenant EBITDA (down slightly from 4.3x in Q1 2026). Debt load remains elevated with a consolidated net secured leverage covenant limit typically at 5.0x. A refinancing effort relies on maintaining the H2 EBITDA recovery.
Decelerating. Down from $160 million in Q1 2026. This includes $57M in cash, $76M under the ABL facility, and $12M in the France factoring facility. The cash burn underscores the urgency of management's goal to reach positive free cash flow for the full year.
Guidance
Stable. Management reiterated their expectation to generate positive free cash flow in 2026. Given the $145M current liquidity and negative net income, achieving this will require disciplined working capital management and the continuation of Q2's EBITDA strength into H2.
Key Questions
Paperboard Divestiture Viability
With the Paperboard & High Yield Pulp segment generating a $27M operating loss this quarter and pricing down 10% due to new U.S. capacity, how viable is a sale of this asset at a fair multiple prior to the conclusion of the strategic review?
Commodities Mix Margin Drag
You successfully shifted CS capacity to CC, driving a 94% volume spike. Given the 11% price decline in CC, what is the cash contribution margin of this substitute volume, and how long can you sustain this mix before logistics/chemical inflation turns it unprofitable?
Strategic Review Outcomes
You expect to communicate a clear path forward in Q4. If the strategic review results in a standalone path rather than a sale, what immediate capital structure actions will be taken to address the 2026/2027 debt maturities?